Trial Profile
Plerixafor for Stem Cell Mobilization in Normal Donors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary) ; Filgrastim (Primary) ; Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions
- 27 Jun 2016 Status changed from active, no longer recruiting to completed.
- 08 May 2015 New trial record